Prestige Consumer Healthcare (PBH) Consolidated Net Income (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Consolidated Net Income came in at $46.7 million in Q4 2025, down 23.49% year-on-year from $61.0 million in Q4 2024, and up 10.63% quarter-over-quarter from $42.2 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Consolidated Net Income (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Consolidated Net Income history runs 16 years deep, the most recent figure standing at $46.7 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 23.49% year-over-year to $46.7 million in Q4 2025; TTM through Dec 2025 was $186.5 million, a 12.82% decrease from a year earlier, with the FY2025 full-year figure at $214.6 million, up 2.52% from the prior year.
  • Consolidated Net Income grew to $46.7 million in Q4 2025 per PBH's latest filing, from $42.2 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $61.0 million in Q4 2024 and bottomed at -$240.6 million in Q1 2023.
  • The 5-year median for Consolidated Net Income is $50.6 million (2021), against an average of $35.9 million.
  • Across the five-year window, Consolidated Net Income plunged 561.84% in 2023 and surged 120.56% in 2024, its largest moves.
  • Year by year, Consolidated Net Income stood at $50.2 million in 2021, then increased by 3.46% to $52.0 million in 2022, then grew by 2.11% to $53.0 million in 2023, then grew by 15.05% to $61.0 million in 2024, then dropped by 23.49% to $46.7 million in 2025.
  • Per Business Quant, the three latest PBH Consolidated Net Income figures stand at $46.7 million (Q4 2025), $42.2 million (Q3 2025), and $47.5 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 370.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 57.00 Mn
10 Prestige Consumer Healthcare 2.41 Bn 2.35 Bn 157.37 Mn 46.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 46.70 Mn
Sep 30, 2025 42.21 Mn
Jun 30, 2025 47.47 Mn
Mar 31, 2025 50.13 Mn
Dec 31, 2024 61.03 Mn
Sep 30, 2024 54.38 Mn
Jun 30, 2024 49.07 Mn
Mar 31, 2024 49.46 Mn
Dec 31, 2023 53.05 Mn
Sep 30, 2023 53.56 Mn
Jun 30, 2023 53.28 Mn
Mar 31, 2023 -240.55 Mn
Dec 31, 2022 51.95 Mn
Sep 30, 2022 51.02 Mn
Jun 30, 2022 55.27 Mn
Mar 31, 2022 52.09 Mn
Dec 31, 2021 50.22 Mn
Sep 30, 2021 45.33 Mn
Jun 30, 2021 57.76 Mn
Mar 31, 2021 35.51 Mn